CINV: Time to Talk

Young oncology patient with doctor

Time to Talk CINV™

After survey results showed that 95% of patients who have experienced chemotherapy-induced nausea and vomiting (also known as CINV) said at some point the side effect had an impact on their daily lives, we knew something more had to be done to help patients. HOPA teamed up with Eisai Inc. and Helsinn Therapeutics (U.S.), Inc. to launch the Time to Talk CINV™ program to help address unmet needs regarding the communication of nausea and vomiting from chemotherapy and ensure that no patient suffers needlessly.

As part of the campaign, the Time to Talk CINV toolkit was created. This action-oriented toolkit is available to patients, their caregivers and their healthcare team to help communicate about the prevention of nausea and vomiting from chemotherapy. Whether a patient is just starting chemotherapy or has been on chemotherapy before and experienced nausea and vomiting, these materials were tailor-made with the guidance of patients, nurses and pharmacists to encourage open communication between the patient, caregiver and healthcare team about nausea and vomiting.

These tools can be printed, filled out digitally, emailed and shared via social medications.

CINV Toolkit

Find the whole CINV Toolkit here.

Patient Checklist

Here's a list of things to ask your healthcare team when starting your chemotherapy regimen. Remember to bring paper or the notes page to jot down information.

Chemotherapy Side Effects Tracker

Find your 30 day tracker here.

Myths and Facts about CINV:

With so many misconceptions about chemotherapy-induced nausea and vomiting, use this tool to learn the facts about this side effect.